Anixa Biosciences, Inc. (ANIX)
NASDAQ: ANIX · Real-Time Price · USD
2.850
-0.040 (-1.38%)
At close: Mar 6, 2026, 4:00 PM EST
3.060
+0.210 (7.37%)
After-hours: Mar 6, 2026, 6:48 PM EST
Anixa Biosciences Income Statement
Financials in millions USD. Fiscal year is November - October.
Millions USD. Fiscal year is Nov - Oct.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Oct '25 Oct 31, 2025 | Oct '24 Oct 31, 2024 | Oct '23 Oct 31, 2023 | Oct '22 Oct 31, 2022 | Oct '21 Oct 31, 2021 |
| Revenue | - | - | 0.21 | - | 0.51 | |
| Cost of Revenue | - | - | 0.16 | - | 0.39 | |
| Gross Profit | - | - | 0.05 | - | 0.13 | |
| Selling, General & Admin | 6.63 | 7.44 | 6.29 | 7.17 | 7.07 | |
| Research & Development | 5.07 | 6.4 | 4.77 | 6.7 | 6.19 | |
| Operating Expenses | 11.7 | 13.83 | 11.06 | 13.88 | 13.26 | |
| Operating Income | -11.7 | -13.83 | -11.01 | -13.88 | -13.14 | |
| Interest & Investment Income | 0.67 | 1.13 | 1.08 | 0.1 | 0 | |
| EBT Excluding Unusual Items | -11.03 | -12.7 | -9.93 | -13.77 | -13.13 | |
| Gain (Loss) on Sale of Assets | - | - | - | - | 0.01 | |
| Pretax Income | -11.03 | -12.7 | -9.93 | -13.77 | -13.13 | |
| Earnings From Continuing Operations | -11.03 | -12.7 | -9.93 | -13.77 | -13.13 | |
| Minority Interest in Earnings | 0.1 | 0.14 | 0.12 | 0.18 | 0.17 | |
| Net Income | -10.93 | -12.55 | -9.81 | -13.6 | -12.95 | |
| Net Income to Common | -10.93 | -12.55 | -9.81 | -13.6 | -12.95 | |
| Shares Outstanding (Basic) | 32 | 32 | 31 | 30 | 29 | |
| Shares Outstanding (Diluted) | 32 | 32 | 31 | 30 | 29 | |
| Shares Change (YoY) | 1.74% | 2.96% | 1.99% | 6.28% | 28.57% | |
| EPS (Basic) | -0.34 | -0.39 | -0.32 | -0.45 | -0.45 | |
| EPS (Diluted) | -0.34 | -0.39 | -0.32 | -0.45 | -0.45 | |
| Free Cash Flow | -7.17 | -7.34 | -6.21 | -6.49 | -4.94 | |
| Free Cash Flow Per Share | -0.22 | -0.23 | -0.20 | -0.21 | -0.17 | |
| Gross Margin | - | - | 23.33% | - | 24.80% | |
| Operating Margin | - | - | -5243.33% | - | -2565.63% | |
| Profit Margin | - | - | -4671.91% | - | -2530.08% | |
| Free Cash Flow Margin | - | - | -2956.67% | - | -964.45% | |
| EBITDA | - | - | - | - | -13.1 | |
| D&A For EBITDA | - | - | - | - | 0.04 | |
| EBIT | -11.7 | -13.83 | -11.01 | -13.88 | -13.14 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.